## 4 Discussion  
The purpose of this research was to collect real-world data and determine if access to services had an impact on utilisation in this important discharge period for ACS patients. The aim of this study was also to demonstrate the innovative use of GPS combined with GIS to objectively measure outcomes \begin{table}
\begin{tabular}{c c c c c} \hline \hline
**No.** & **Item** & **Source** & **Question/Activity** &
\begin{tabular}{c} _n (\%)_ **Achieved or** **Recalled** \\ \end{tabular} \\ \hline
1. & \begin{tabular}{c} Know your diagnosis and the \\ cardiac procedures you have had \\ \end{tabular} & \begin{tabular}{c} Knowledge quiz \\ (Table 3) \\ \end{tabular} & \
\begin{tabular}{c} Diagnosis \\ Procedures \\ \end{tabular} &
\begin{tabular}{c} \(18\) (100) \\ 4.3 (24.1) \\ \end{tabular} \\ \hline
2. & \begin{tabular}{c} Understand your risk factors \\ \end{tabular} & \begin{tabular}{c} Knowledge quiz \\ (Table 3) \\ \end{tabular} & \
\begin{tabular}{c} Medical history \\ Conditions that can \\ affect the heart \\ Discharge advice \\ \end{tabular} &
\begin{tabular}{c} 6 (35.0) \\ 2 (11.1) \\ 11.2 (62.2) \\ \end{tabular} \\ \hline
3. & Go to cardiac rehabilitation & \begin{tabular}{c} Global Positioning \\ System (GPS) data \\ \end{tabular} & \
\begin{tabular}{c} Attended CR location \\ at 0–30 days \\ Attended CR location \\ at 31–90 days \\ \end{tabular} &
\begin{tabular}{c} 2 (16.7) \\ 3 (25.0) \\ \end{tabular} \\ \hline
4. & Take your medications & \begin{tabular}{c} GPS data: visits to \\ nominated \\ pharmacist location \\ \end{tabular} & \
\begin{tabular}{c} Tracked to pharmacist \\ location at 0–30 days \\ \end{tabular} &
\begin{tabular}{c} 13 (72.2) \\ 11 (61.1) \\ \end{tabular} \\ \hline
5. & \begin{tabular}{c} Know your warning signs of heart \\ attack and respond appropriately \\ \end{tabular} & \begin{tabular}{c} “My Heart My Life” \\ Heart Foundation \\ booklet \\ \end{tabular} & \
\begin{tabular}{c} Was a copy of “My \\ Heart My Life” \\ received \\ \end{tabular} &
\begin{tabular}{c} 16 (88.9) \\ 10 (62.5) \\ 7 (43.8) \\ \end{tabular} \\ \hline
6. & \begin{tabular}{c} See your doctor (General \\ Practitioner) regularly \\ \end{tabular} & \begin{tabular}{c} GPS data: visits to \\ nominated GP \\ location \\ \end{tabular} & \
\begin{tabular}{c} No. of visits to GP \\ 0–30 days \\ No. of visits to GP \\ 31–90 days \\ \end{tabular} &
\begin{tabular}{c} 10 (62.5) \\ 7 (43.8) \\ \end{tabular} \\ \hline \hline \end{tabular}
\end{table} 
Table 5: Overall scorecards for adherence to discharge advice (6 steps). and explore if patients implemented recommended activity and utilisation of healthcare services (CR, pharmacy, general practice, pathology and emergency department) in the first 30 days and 90 days after discharge from hospital. Our recruitment plan was to recruit DiNovo ACS patients at discharge including fifty percent Aboriginal and Torres Strait Islander people and non-indigenous people equally from metro and rural and remote areas. Review of our recruitment data indicated that during the recruitment period sixteen of the eighteen potential Aboriginal people screened had had a previous ACS event and were therefore not eligible to participate. The demographic and clinical characteristics of participants mean age of the participants was 55.8 years, the majority were male, 60% STEMI mean of four risk factors per person (range 2-8) were consistent with other studies reporting the characteristics of Australia ACS patients [25; 26]. At the recruitment phase enthusiasm was related high with only 10% of those approached declining to participate. This group, which was mostly male, reported high levels of satisfaction with participating in the study. Our conclusion to the high levels of enthusiasm was the participation incentive of a free phone. However, this was moderated by adherence to the study protocol. At completion of the study, 18 (95%) of participants had provided 30 days of tracking data and 15 (83%) of participants provided 90 days of tracking data.